Research ArticleClinical Studies

Hepatic Arterial Infusion Chemotherapy for Metastatic Breast Cancer Patients With Resistance to Standard Systemic Chemotherapies

MITSUHIRO FURUTA, JUNICHIRO WATANABE, TAKESHI ARAMAKI, AKIFUMI NOTSU and HIROFUMI YASUI
In Vivo January 2020, 34 (1) 275-282; DOI: https://doi.org/10.21873/invivo.11771

Article Information

vol. 34 no. 1 275-282
DOI 
https://doi.org/10.21873/invivo.11771
PMID 
31882489
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received September 8, 2019
  • Revision received October 1, 2019
  • Accepted October 14, 2019
  • Published online December 27, 2019.
Copyright & License 
Copyright © 2020 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. MITSUHIRO FURUTA1,2,
  2. JUNICHIRO WATANABE1⇑,
  3. TAKESHI ARAMAKI3,
  4. AKIFUMI NOTSU4 and
  5. HIROFUMI YASUI2
  1. 1Division of Breast Oncology, Shizuoka Cancer Center, Shizuoka, Japan
  2. 2Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan
  3. 3Division of Interventional Radiology, Shizuoka Cancer Center, Shizuoka, Japan
  4. 4Clinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan
  1. Correspondence to: Junichiro Watanabe, Division of Breast Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka 411-8777, Japan. Tel: +81 559895222, Fax: +81 559895783, e-mail: j.watanabe{at}scchr.jp
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Hepatic Arterial Infusion Chemotherapy for Metastatic Breast Cancer Patients With Resistance to Standard Systemic Chemotherapies
MITSUHIRO FURUTA, JUNICHIRO WATANABE, TAKESHI ARAMAKI, AKIFUMI NOTSU, HIROFUMI YASUI
In Vivo Jan 2020, 34 (1) 275-282; DOI: 10.21873/invivo.11771
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords